...
首页> 外文期刊>Infection >HBV whole-genome mutation profile in HIV-1/HBV coinfected patients in a long-term follow-up study
【24h】

HBV whole-genome mutation profile in HIV-1/HBV coinfected patients in a long-term follow-up study

机译:长期随访研究中HIV-1 / HBV合并感染患者的HBV全基因组突变谱

获取原文
获取原文并翻译 | 示例
           

摘要

Purpose: Human immunodeficiency virus (HIV-1)-infected patients frequently harbour hepatitis B and C viruses (HBV and HCV, respectively). Possible modifications of the natural history of hepatitis B may occur. The aim of this study was to characterise HBV diversity and evolutionary and mutational viral genome profiles in HIV-1/HBV coinfections. Methods: HIV-1 and HBV markers determinations (Roche, FRG; Abbott, USA) and HBV genome-length retrospective analysis were performed in follow-up isolates from patients who were either stably HBsAg-negative with a low level of HBV DNA (occult hepatitis B infection, OBI) or HBsAg-positive with a high level of HBV DNA. Phylogenetic analysis (maximum likelihood method, MEGA5), statistical analysis and evolutionary rates calculation (d S/d N) were applied. Results: Positive selection pressures in the PreS/S region and a significantly higher number of mutations in this region including the major hydrophilic region (MHR) and the "a" determinant were shown in HBsAg-negative (possibly OBI) compared to stably HBsAg-positive HIV-1/HBV subgenotypes D3/A2 coinfected patients. Mutants previously described in HIV-1/HBV coinfected patients were found. Known mutants Y100C, P127T and P120A associated to Y134H and S143T and new S mutants, which may potentially affect HBsAg expression and secretion and anti-HBs binding, were detected in baseline sera persisting up to the end of 9 years follow-up. Known mutations of BCP, Pre-C, C and X regions were also characterised. Natural mutants strictly known as being involved in diagnostic failure were not detected; however, numerous corresponding sites showed amino acid variations. Conclusions: Evolutionary and genotypic differences observed, particularly in the PreS/S region, between HBsAg-negative (OBI) and HBsAg-positive HIV-1/HBV coinfected patients, may contribute, in association with mutations of other genomic regions, to the HBsAg-negative phenotype.
机译:目的:感染人类免疫缺陷病毒(HIV-1)的患者经常携带乙型和丙型肝炎病毒(分别为HBV和HCV)。可能会发生乙型肝炎自然病史的可能改变。这项研究的目的是表征HIV-1 / HBV合并感染中的HBV多样性以及进化和突变病毒基因组图谱。方法:在来自稳定的HBsAg阴性且HBV DNA水平低的患者(隐匿性)的随访分离物中,进行了HIV-1和HBV标志物测定(Roche,FRG;美国雅培)和HBV基因组长度回顾性分析。乙型肝炎病毒感染(OBI)或HBsAg阳性且HBV DNA水平高。应用了系统发育分析(最大似然法,MEGA5),统计分析和进化速率计算(d S / d N)。结果:与稳定的HBsAg-阳性HIV-1 / HBV亚型D3 / A2并发感染。发现了先前在HIV-1 / HBV合并感染患者中描述的突变体。在基线血清中检测到与Y134H和S143T相关的已知突变体Y100C,P127T和P120A,以及可能潜在影响HBsAg表达,分泌和抗HBs结合的新的S突变体,这些血清持续到9年随访结束。还对BCP,Pre-C,C和X区的已知突变进行了表征。没有发现严格被认为与诊断失败有关的天然突变体;然而,许多相应的位点显示氨基酸变异。结论:HBsAg阴性(OBI)和HBsAg阳性HIV-1 / HBV合并感染患者之间观察到的进化和基因型差异,特别是在PreS / S区,可能与其他基因组区域的突变有关。 -阴性表型。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号